Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Immunic Inc (NQ: IMUX ) 1.420 +0.030 (+2.16%) Streaming Delayed Price Updated: 11:52 AM EDT, Jul 26, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Headline News about Immunic Inc < Previous 1 2 3 4 5 Next > Peek Behind the Curtain: 7 Penny Stocks With Heavy Insider Buying May 23, 2024 While speculative ideas are treacherous, you can possibly reduce your blood pressure with these penny stocks with insider buying. Via InvestorPlace Immunic CMO discusses role of clinical trials in biotech development for Clinical Trials Day May 20, 2024 Immunic CMO discusses role of clinical trials in biotech development for Clinical Trials Day Via News Direct Immunic chief medical officer discusses promising treatments to mark World IBD Day May 17, 2024 Immunic chief medical officer discusses promising treatments to mark World IBD Day Via News Direct Immunic highlights IMU-856 gastrointestinal candidate to mark International Celiac Day May 16, 2024 Immunic highlights IMU-856 gastrointestinal candidate to mark International Celiac Day Via News Direct Immunic CEO Dr Daniel Vitt discusses key Q1 advances and upcoming milestones May 09, 2024 Immunic CEO Dr Daniel Vitt discusses key Q1 advances and upcoming milestones Via News Direct Topics Intellectual Property Exposures Intellectual Property IMUX Stock Earnings: Immunic Misses EPS for Q1 2024 May 08, 2024 IMUX stock results show that Immunic missed analyst estimates for earnings per share the first quarter of 2024. Via InvestorPlace Immunic's Earnings Outlook February 21, 2024 Via Benzinga Immunic: Q3 Earnings Insights November 14, 2023 Via Benzinga A Preview Of Immunic's Earnings November 13, 2023 Via Benzinga Immunic Phase 2 EMPhASIS trial data highlighted in peer-reviewed neurology journal May 01, 2024 Immunic Phase 2 EMPhASIS trial data highlighted in peer-reviewed neurology journal Via News Direct Immunic CMO discusses complexities of multiple sclerosis to mark MS Awareness Month March 21, 2024 --News Direct-- Via News Direct Immunic And 2 Other Stocks Under $2 Insiders Are Buying February 29, 2024 The Dow Jones index closed lower by over 20 points on Wednesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders... Via Benzinga Topics Stocks Exposures US Equities What's Going On With Immunic Stock? January 05, 2024 Immunic, Inc. (NASDAQ: IMUX) shares are roughly flat following strength early Friday after the company announced a three-tranche private placement of up to $240 million. Via Benzinga 12 Health Care Stocks Moving In Friday's Pre-Market Session January 05, 2024 Via Benzinga Immunic "super excited" about latest PMS trial data October 11, 2023 --News Direct-- Via News Direct Immunic Inc eyeing "big step" for multiple sclerosis patients July 25, 2023 --News Direct-- Via News Direct Immunic Inc set to bring relief with encouraging results May 16, 2023 Immunic Inc set to bring relief with encouraging results Via News Direct Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday January 05, 2024 Pre-market stock movers are worth checking on Friday as we lay out all of the biggest stories worth keeping tabs on this morning! Via InvestorPlace Immunic CSO hails "great" progress with MS program October 24, 2023 --News Direct-- Via News Direct Why Startek Shares Are Trading Higher By 29%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session October 10, 2023 Gainers SuperCom Ltd. (NASDAQ: SPCB) shares jumped 89% to $0.6805, after falling 13% on Monday. Via Benzinga Recap: Immunic Q1 Earnings May 11, 2023 Via Benzinga 12 Health Care Stocks Moving In Tuesday's Pre-Market Session October 10, 2023 Via Benzinga Multiple Sclerosis Impacts 1M People In US - Immunic Reveals 'Positive' Data From Nerve Disorder Candidate October 10, 2023 Immunic Inc (NASDAQ: IMUX) announced interim data from its phase 2 CALLIPER trial of nuclear receptor-related 1 (Nurr1) activator, vidofludimus calcium (IMU-838), in patients with Via Benzinga Why Immunic Shares Are Trading Higher By Around 13%; Here Are 20 Stocks Moving Premarket October 10, 2023 Gainers SuperCom Ltd. (NASDAQ: SPCB) shares rose 78.4% to $0.6425 in pre-market trading, after falling 13% on Monday. Via Benzinga Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday October 10, 2023 It's time to dive into the biggest pre-market stock movers with all the most recent news moving shares on Tuesday morning! Via InvestorPlace 12 Health Care Stocks Moving In Monday's After-Market Session October 09, 2023 Via Benzinga Immunic CEO hails "great day" after completing IMU-838 phase 2 trial enrolment August 21, 2023 --News Direct-- Via News Direct Immunic CEO says Q2 results "couldn't be better" August 07, 2023 --News Direct-- Via News Direct 12 Health Care Stocks Moving In Wednesday's Intraday Session July 05, 2023 Via Benzinga 12 Health Care Stocks Moving In Wednesday's Intraday Session June 28, 2023 Via Benzinga < Previous 1 2 3 4 5 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
